High-precision preclinical research instruments designed for Malaysian academic, pharmaceutical, and GLP laboratories.
Beijing Huironghe Technology Co., Ltd., (overseas brand "HRHINS") founded in 2010 with a registered capital of 10 million yuan, is located in the Beijing Economic-Technological Development Area. The company specializes in the R&D, production, sales, and technical services for inhalation toxicity, genetic toxicity, inhaler testing, aerosol detection, and lab automation systems.
HRHINS has been recognized as a National High-tech Enterprise and designated as a Beijing Municipal Corporate Science and Technology R&D Institution. Additionally, it has received honors such as being a Beijing "Specialized, Refined, Unique, and Innovative" SME, a China Manufacturing Champion Enterprise, and a Beijing Intellectual Property Demonstration Enterprise.
Further accolades include being named a National Intellectual Property Advantage Enterprise in 2019, a National "Little Giant" SME (the first in the aerosol scientific instrument field) in 2022, and a recipient of the Second Prize in Scientific and Technological Progress from the Tianjin Municipal Government in 2022.
Our dedicated team focuses on translating cutting-edge aerosol physics and respiratory physiology into reliable laboratory hardware. With over a decade of continuous development, we supply state-of-the-art systems globally, helping researchers study biological responses to inhaled substances with unmatched precision.
In the expanding Southeast Asian market, particularly Malaysia, HRHINS is committed to supporting local CROs, universities, and environmental monitoring bodies in upgrading their toxicological capabilities.
The biomedical research landscape in Malaysia is undergoing a significant transformation. Under the driving force of the National Biotechnology Policy 2.0 and the Third Industrial Master Plan (IMP3), Malaysia is rapidly establishing itself as a key hub for clinical and preclinical research in Southeast Asia. This growth has created an unprecedented demand for advanced physiological testing equipment, particularly in the field of respiratory toxicology and pulmonary function assessment. Consequently, Non-Invasive Plethysmography (NIP) systems have become critical tools for researchers nationwide.
Non-invasive plethysmography, specifically Whole-Body Plethysmography (WBP), allows for the continuous monitoring of respiratory parameters in conscious, unrestrained subjects. By avoiding the confounding effects of anesthesia and invasive surgery, this technology provides highly accurate, physiologically relevant data on parameters such as tidal volume, minute volume, respiratory rate, and PenH (enhanced pause). For Malaysian laboratories, adopting these advanced systems is essential to align with international GLP (Good Laboratory Practice) guidelines and secure global acceptance of their research data.
Several localized factors are accelerating the adoption of non-invasive plethysmography systems across Malaysia:
The global scientific community's commitment to the 3Rs (Replacement, Reduction, and Refinement) is strongly reflected in Malaysia's academic policies. Non-invasive plethysmography represents a major step forward in "Refinement," as it minimizes animal stress and allows for longitudinal studies where the same subject can be monitored over weeks or months. This reduces the total number of subjects required for statistical significance.
Furthermore, integration with AI and lab automation is the defining trend of the modern research equipment industry. Modern NIP systems feature automated calibration, real-time data analysis, and environmental control systems that maintain stable temperature and humidity levels inside the chambers. This level of automation ensures high reproducibility and minimizes human error, which is crucial for laboratories seeking ISO/IEC 17025 accreditation in Malaysia.
In practice, NIP systems are deployed across diverse research environments in the country:
The company occupies over 3000sqm of offices, R&D center and workshops, ensuring state-of-the-art production capabilities.
HRHINS holds certifications for the ISO 9001:2015 Quality Management System, ISO 14001:2015 Environmental Management System, ISO 45001:2018 Occupational Health and Safety Management System, and GB/T 29490-2013 Intellectual Property Management System.
In 2018, HRHINS supported the establishment of the Respiratory Toxicology Committee of the Chinese Society of Toxicology and became its founding sponsor. The company also gained council membership in prestigious organizations, including the Chinese Society of Toxicology and the Chinese Environmental Mutagen Society.
Independently developed intellectual property covering the entire workflow of aerosol generation, detection, and analysis.

HRHINS has developed over 60 innovative instruments, including aerosol generators, inhalation systems, fully automated QuEChERS system, multi-stage cascade impactor, and breathing simulator, etc.
The aerosol toxicity instrument line offers a complete suite for studies involving rats, mice, guinea pigs, ferrets, rabbits, dogs, and monkeys. Supported exposure methods are equally comprehensive, covering nose-head, whole-body, airborne infection, and in vitro cell culture exposures.
Crucially, all products—from aerosol generation and detection to sampling and system control—are based on independent intellectual property.
These solutions are widely employed by GLP laboratories, safety assessment centers, universities, research institutions, and hospital respiratory departments. Thanks to their superior quality and reliable after-sales support, our products have earned the trust of users both in China and internationally.
Explore our full range of exposure and plethysmography systems tailored for the Malaysian scientific community.